Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hossain

Showing results (641-650 of 651) with videos related to

Pageof 66
Sort By:
Cell Death & Disease|August 21, 2020
Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activationAbu Shadat M Noman, Rashed R Parag, Muhammad I Rashid, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 9, 2024
Conversion to open surgery in obese patients undergoing minimally invasive distal pancreatectomy: results from a multicenter analysisFabio Ausania, Carolina Gonzalez-Abós, Filippo Landi, et al.
Virology Journal|November 13, 2024
Genomic epidemiology of early SARS-CoV-2 transmission dynamics in BangladeshL Carnegie, J T McCrone, L du Plessis, et al.
Blood Advances|July 30, 2025
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR AnalysisHemalatha G Rangarajan, Prakash Satwani, Megan M Herr, et al.
Blood Advances|April 25, 2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood Neoplasia|March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomasAbu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood Advances|April 25, 2024
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minoritiesNandita Khera, Sikander Ailawadhi, Ruta Brazauskas, et al.
Leukemia & Lymphoma|July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patientsBei Hu, Xiao Lin, Hans C Lee, et al.
Nature Medicine|July 27, 2021
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trialJay Y Spiegel, Shabnum Patel, Lori Muffly, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Pageof 66

Showing results (641-650 of 651) with videos related to

Sort By:
Pageof 66
Cell Death & Disease|August 21, 2020
Chemotherapeutic resistance of head and neck squamous cell carcinoma is mediated by EpCAM induction driven by IL-6/p62 associated Nrf2-antioxidant pathway activationAbu Shadat M Noman, Rashed R Parag, Muhammad I Rashid, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 9, 2024
Conversion to open surgery in obese patients undergoing minimally invasive distal pancreatectomy: results from a multicenter analysisFabio Ausania, Carolina Gonzalez-Abós, Filippo Landi, et al.
Virology Journal|November 13, 2024
Genomic epidemiology of early SARS-CoV-2 transmission dynamics in BangladeshL Carnegie, J T McCrone, L du Plessis, et al.
Blood Advances|July 30, 2025
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR AnalysisHemalatha G Rangarajan, Prakash Satwani, Megan M Herr, et al.
Blood Advances|April 25, 2018
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysisNirav N Shah, Kwang Woo Ahn, Carlos Litovich, et al.
Blood Neoplasia|March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomasAbu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood Advances|April 25, 2024
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minoritiesNandita Khera, Sikander Ailawadhi, Ruta Brazauskas, et al.
Leukemia & Lymphoma|July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patientsBei Hu, Xiao Lin, Hans C Lee, et al.
Nature Medicine|July 27, 2021
CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trialJay Y Spiegel, Shabnum Patel, Lori Muffly, et al.
JAMA Oncology|January 13, 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated DonorsGuru Subramanian Guru Murthy, Soyoung Kim, Zhen-Huan Hu, et al.
Pageof 66